Objective: The evolution toward more stringent conceptualizations of remission in family therapy for adolescent anorexia nervosa (AN) has, with time, introduced variability in outcomes across randomized controlled trials (RCTs). An examination of remission across the history of research on family therapy for AN shows that earlier studies adopted lenient definitions and generally yielded higher rates of remission than studies of the past decade that have used stricter definitions of remission. In this study, we investigate the reactivity of remission rates to the application of different definitions of remission used within the family therapy for AN literature, within a single RCT data set.
T A B L E 1 Definitions and rates of remission at end-of-treatment and follow-up in randomized clinical trials of family interventions for adolescent anorexia nervosa
Study
Sample characteristics Definition of remission Treatment component % remitted Russell et al., 1987 & Eisler et al., 1997 N = 10 a 100% female 12-18 years <3 years duration AN "Good" or "intermediate" Morgan Russell Scale (MRS) Family therapy (FT) 90 FT (5 years) 90
Le Grange, Eisler, Dare, & Russell, 1992 Early treatment studies (Eisler et al., 2000; Russell, Szmukler, Dare, & Eisler, 1987) defined outcomes primarily as a function of weight status.
Embedded within the psychopathology of AN, emaciation represents a cardinal sign of illness. Low body weight is clinically significant in its own right and often portends an array of medical complications, including cardiac abnormalities and amenorrhea (Mehler & Brown, 2015) ; it is also an obstacle to change and a driver of cognitive symptoms, that is, fear of weight gain, drive for thinness (Accurso, Ciao, Fitzsimmons-Craft, Lock, & Le Grange, 2014) . Reversing the state of starvation is therefore a priority in any intervention for AN. To this end, weight measurements are a key indicator of treatment response, even when cognitive remission lags behind physical remission (Murray, Quintana, Loeb, Griffiths, & Le Grange, 2019) . Moreover, weight measures have the added benefit of being relatively objective in comparison to the self-reported cognitive features of AN, particularly for adolescents (Bravender et al., 2010) .
Despite the importance of weight-based outcomes, this narrow measure has been reconsidered over time within wider questioning in the field regarding how to optimally operationalize AN recovery, a construct that goes beyond remission in scope and duration (Bardone-Cone et al., 2010; Couturier & Lock, 2006a; Dawson, Rhodes, & Touyz, 2015) . Given the fragility of partial clinical improvement (Khalsa, Portnoff, McCurdy-McKinnon, & Feusner, 2017) , and the high risk of chronicity in AN (Eddy et al., 2017; Fichter, Quadflieg, Crosby, & Koch, 2017; Herpertz-Dahlmann et al., 2018) , it has been argued that the bar for clinical efficacy in AN RCTs should be set high.
In this earnest effort, aptly highlighted by Bardone-Cone, Hunt, and
Watson (2018) from which FBT derives . Table 1 summarizes the definitions and rates of remission described in each of these studies, apart from two in which remission rates were not reported as outcomes (Geist, Heinmaa, Stephens, Davis, & Katzman, 2000; Lock, Fitzpatrick, Agras, Weinbach, & Jo, 2018) . Across these studies, rates of remission at end-of-treatment and follow-up varied from 21% to 96%. Notably, remission rates in earlier studies (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) outcomes are considered to be treatment success as compared to "poor" outcome (Morgan & Hayward, 1988; Morgan & Russell, 1975; Russell et al., 1987) . Applying this scale in a somewhat redacted format, patients achieve "good" outcome when they maintain their weight above 85% mBMI a (median body mass index), have no binge eating or purging behavior, and menstruate (for postmenarchal females). "Intermediate" outcome involves the same weight criterion, but patients are either not menstruating or experiencing bulimic symptoms on an average of less than once per week over the past month. Patients are described as having "poor" outcome when their This report describes the stratified subgroup of AN with onset before 18 years of age and duration of illness less than 3 years, which yielded a primarily adolescent sample (M = 16.6 years old, SD = 1.7). Other AN subgroups in this study extended to older individuals (Subgroup 2 M = 20.6 years old, SD = 4.0; Subgroup 3 M = 27.7 years old, SD = 7.8) by virtue of age of onset and/or duration of illness. Please see original study for further details. b Although the original study did not report the frequency or percent remitted, these data were later reported in a meta-analysis weight is less than 85% mBMI or they experience more frequent bulimic symptoms. Thus, using the Morgan Russell Scale, allows one to meet criteria for remission (i.e., "good"
by having a body weight ≥85% mBMI with bulimic symptoms occurring on average less than once per week over the past month.
Studies using the Morgan-Russell scale have reported remission rates ranging from 47% to 90% (Ball & Mitchell, 2004; Eisler et al., 1997; Eisler et al., 2000; Eisler et al., 2007; Eisler et al., 2016; Le Grange et al., 1992; Russell et al., 1987) . Likewise, other early studies (Lock et al., 2005; Robin et al., 1999) Recent studies have used more rigorous definitions of remission.
First, the more conservative threshold of ≥95% mBMI is now commonly used to delineate weight restoration Le Grange et al., 2014; Le Grange et al., 2016; Lock et al., 2010; Lock et al., 2015;  Madden, Miskovic-Wheatley, Wallis, Kohn, Lock, et al., 2015b) , given evidence that this threshold best predicts longer-term recovery for adolescents with AN . In FBT studies using this higher threshold, reported rates of remission range from 33% to 63% Lock et al., 2015) . Second, beginning with Lock et al. (2005) , studies have frequently incorporated the Eating Disorder Examination (EDE) (Fairburn, Cooper, & O'Connor, 2014) to assess change of cognitive and behavioral symptoms of AN over the course of FBT. Although the EDE assesses frequency of bulimic symptoms, these particular behavioral data are not incorporated in the EDE Global score.
In combining weight and cognitive symptoms, remission has been defined as ≥95% mBMI plus EDE Global score within one standard deviation (SD) of community norms (≤1.59) (Fairburn & Beglin, 1994) . Lock
and Le Grange were the first to employ this combined criterion set in a multisite RCT that compared FBT to adolescent-focused individual therapy (Lock et al., 2010) . When using this strict definition of combined weight and cognitive remission, rates of remission in studies of FBT have ranged from 21% to 43% (Le Le Grange et al., 2016; Lock et al., 2010; Madden, Miskovic-Wheatley, Wallis, Kohn, Lock, et al., 2015b) . A similar definition that uses the same weight cutoff, but an EDE global score within 2 SDs of community norms (≤2.52), has been applied in some studies (Lock, Couturier, Bryson, & Agras, 2006; Madden, Miskovic-Wheatley, Wallis, Kohn, Hay, et al., 2015a) . However, this definition has not been reported as a main outcome in randomized studies of FBT.
An early study by Couturier and Lock (2006b) how the definition of remission affects reported outcomes, a crucial endeavor in parsing out the efficacy of this intervention across its history. We hypothesized there would be significant variability in the derived remission rates, with definitions using weight only, low weight thresholds and/or no amelioration of cognitive or behavioral symptoms, yielding higher remission rates compared to definitions requiring higher thresholds on these parameters.
| METHOD
Data for this secondary analysis were derived from a single-site RCT from Melbourne, Australia which compared the relative efficacy of conjoint FBT and parent-focused treatment (PFT), a separated-format variant of FBT (Le Grange et al., 2016) . The data that support the findings of this study are available from the corresponding author upon reasonable request. For the purpose of this analysis, we combined the full sample of the RCT rather than separating the two conditions. Specifically, conjoint FBT and PFT are variants of the same core intervention; our goal was not to parse out differential responses to treatment among the multiple versions of family therapy for AN, nor to perform a reanalysis of the primary outcome in the main study hypotheses.
Participants were 106 adolescents (M = 15.5, SD = 1.5) who met a DSM-IV diagnosis of AN with two modifications in alignment with the proposed diagnostic criteria for AN within DSM-5, which had an anticipated publication timeline during the course of this RCT. As reported in the main outcome manuscript (Le Grange et al., 2016) , the study did not apply the amenorrhea criterion and applied greater flexibility in operationalizing low weight status, that is, ≤90% mBMI for adolescents ≤75th percentile for height, and <95% mBMI for adolescents ≥75th percentile for height. At baseline, participants' mean %mBMI was 81.9
(SD = 6.1), and mean duration of illness was 10.5 months (SD = 8.8, range excluding those with missing bulimic symptom data produced a remission rate of 66% (62 of 94) c (see Figure 1 ).
When remission was defined in the 106 cases using EDE Global scores alone, the following remission rates were obtained: 87.7% at EDE Global within 2 SDs of community norms, and 77.4% at EDE Global within 1 SD of community norms. Combining weight status with the EDE yielded the following rates of remission: 37.7% ≥ 95% mBMI plus EDE Global within 2 SDs of norms, and 32.1% ≥ 95% mBMI plus EDE Global within 1 SD of norms. Cochran's Q test for related samples was significant [χ 2 (10, N = 106) = 303.55, p = .000].
| DISCUSSION
Exploring the reactivity of remission rates to the application of various criteria that have been used to define treatment response in AN family treatment research confirmed a broad range of statistically distinct remission rates within a single data set. These outcomes can be consolidated into three categories. First, when the definition of remission incorporated only weight status, with the threshold set low (e.g., BMI > 17.5 or ≥85% mBMI), or only cognitive remission, as represented by an EDE Global score within one or two SDs of community norms, remission was achieved by a majority of patients (>75% on average). Second, when the weight threshold was set higher (e.g., BMI ≥ 25th percentile, or at least 90%mBMI), or using the Morgan Russell Scale "good" plus "intermediate" categories, the remission rate was approximately 60%. The third definition used a high weight threshold with a BMI > 50th percentile, or minimum 95%mBMI, or the latter weight threshold with the EDE Global score within one or two SDs of community norms, but did not include behavioral criteria (i.e., binge eating/purging). Remission was achieved in about one third of patients. The RCT from which these secondary analyses were undertaken applied this latter definition of remission and correspondingly found that about one third of patients achieved remission at end-of-treatment (Le Grange et al., 2016) . The consequence of changing the definition of remission is clearly demonstrated; if any of the first definition criteria were applied to this RCT sample, remission rates would have appeared similar to those in the earlier family therapy studies (e.g., Eisler et al., 2000; Russell et al., 1987) . Or to put it slightly differently, remission rates in the most recently published RCT for family therapy would have been above 80%, that is, identical to that in the seminal study published in 1987 (Russell et al., 1987) . While implications of vari- c. Of 106 participants, 13 were missing each of the bulimic symptom items on the EDE (e.g., frequency of objective binging, self-induced vomiting, laxative misuse, and driven exercise). Of those 13:1 was also missing weight, 5 were below 85% mBMI, and 7 were above 85% mBMI. Hypothetically, if each of these 7 individuals did not have bulimic symptoms, 65% of the sample would have been considered remitted. discharge from care could be premature and put their patients at greater risk of relapse.
Our results, together with those of Couturier and Lock (2006b) and Madden, Miskovic-Wheatley, Wallis, Kohn, Hay, et al. (2015a) , to be worsening over time-under the assumption of an "apples to apples" rather than "apples to oranges" set of comparisons-even as manualization and implementation of this treatment have been considerably refined during this period (Couturier & Kimber, 2015; . As such, the risk is that treatment efficacy may be understated when higher thresholds for remission are applied. This is particularly significant as newer adaptations of FBT (e.g., varying delivery format) that utilize outcome criteria that include both weight and cognitive recovery are being carefully scrutinized for their efficacy.
Understanding the implications of different definitions of remission are critical to ensure that appropriate comparisons are made. A failure to consider the greater stringency of these later remission criteria could result in false inferences concerning the execution and efficacy of family therapy over time and across investigators.
Our study raises at least two questions for consideration: (a) do the findings challenge the purported efficacy of FBT, and (b) can these findings inform consensus on a core outcome set for eating disorders, as promulgated by the COMET initiative (Core Outcome Measures in Effectiveness Trials-(http://www.comet-initiative.org)? In addressing the first questions, it is important to note that the current study was not designed to empirically identify the best measure of efficacy of FBT, or directly address the efficacy of FBT. That said, our findings help explain, rather than challenge the purported efficacy of FBT.
Going forward, there is a need for research which examines the reliability, construct validity, and predictive validity of the various definitions of remission to inform such recommendations (c.f., Madden, Miskovic-Wheatley, Wallis, Kohn, Hay, et al., 2015a) .
This would in turn assist in addressing the second question, which is to consider what constitutes the core outcome definition, as endorsed by COMET, that should be reported for future efficacy trials in adolescent AN. We not only argue for agreement in the field for a uniform approach to reporting remission, but also advocate for a definition of remission that, at a minimum, should strive to set the bar for (a) weight status at a level that would support growth, bone health, hormonal functioning, and cognitive development in adolescents (e.g., ≥95%
mBMI), and (b) eating-and body-related cognitive, as well as (c) behavioral status at levels that reflect normal development (e.g., EDE Global Score within 1 SD of the community norm and an absence of binge eating or purging). Venturing to suggest a definition of remission that can be applied transdiagnostically and across age groups, while much needed, is outside the scope of this manuscript.
Findings from the current study offer important insights into the potential challenges of between-trial comparisons across stud- 
